Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Yoko Narasaki"'
Autor:
Yoko Narasaki, Csaba P. Kovesdy, Amy S. You, Keiichi Sumida, Yamini Mallisetty, Satya Surbhi, Fridtjof Thomas, Alpesh N. Amin, Elani Streja, Kamyar Kalantar-Zadeh, Connie M. Rhee
Publikováno v:
The Lancet Regional Health. Americas, Vol 36, Iss , Pp 100814- (2024)
Summary: Background: We examined the real-world comparative safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i) vs. other newer anti-glycemic medications (dipeptidyl peptidase-4 inhibitors [DPP4i], glucagon-like peptide-1 receptor agonists [
Externí odkaz:
https://doaj.org/article/578ff3bab1c544c8928fcc8422957606
Autor:
Rhee, Connie M., You, Amy S., Yoko Narasaki, Brent, Gregory A., Sim, John J., Kovesdy, Csaba P., Kalantar-Zadeh, Kamyar, Nguyen, Danh V.
Publikováno v:
Journal of Clinical Endocrinology & Metabolism; Nov2023, Vol. 108 Issue 11, pe1374-e1383, 10p
Autor:
Connie M. Rhee, Amy S. You, Victoria Page, Glen Hayashida, Merle Kataoka-Yahiro, James Davis, Linda L. Wong, Yoko Narasaki, Kamyar Kalantar-Zadeh
Publikováno v:
Nephron. :1-10
Background: Several studies suggest that Asian-American and Native Hawaiian and Other Pacific Islander (NHOPI) racial/ethnic groups have a heightened risk of chronic kidney disease (CKD), but provide limited inference due to the aggregation of these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::986d2e9a5bc580261ea4c5aa6cb28694
https://doi.org/10.1159/000527990
https://doi.org/10.1159/000527990
Autor:
Yoko Narasaki, Amy S You, Shaista Malik, Linda W Moore, Rachelle Bross, Mackenzie K Cervantes, Andrea Daza, Csaba P Kovesdy, Danh V Nguyen, Kamyar Kalantar-Zadeh, Connie M Rhee
Publikováno v:
The American Journal of Clinical Nutrition. 116:1123-1134
In healthy adults, higher dietary potassium intake is recommended given that potassium-rich foods are major sources of micronutrients, antioxidants, and fiber. Yet among patients with advanced kidney dysfunction, guidelines recommend dietary potassiu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65095856db0e9e50c40bf4611f991e10
https://doi.org/10.1093/ajcn/nqac215
https://doi.org/10.1093/ajcn/nqac215
Autor:
Yoshikazu Miyasato, Ramy M. Hanna, Tsuyoshi Miyagi, Yoko Narasaki, Hiroshi Kimura, Jun Morinaga, Masashi Mukoyama, Kamyar Kalantar‐Zadeh
Publikováno v:
Hemodialysis International.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b2cd8f2fbec141f48cb501c8881a360
https://doi.org/10.1111/hdi.13094
https://doi.org/10.1111/hdi.13094
Autor:
Connie M Rhee, Amy S You, Yoko Narasaki, Gregory A Brent, John J Sim, Csaba P Kovesdy, Kamyar Kalantar-Zadeh, Danh V Nguyen
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
Context Hypothyroidism is a common yet under-recognized condition in chronic kidney disease (CKD) patients, which may lead to end-organ complications if left untreated. Objective We developed a prediction tool to identify CKD patients at-risk for inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::222af6b2a7af64994936620ed229d95d
https://doi.org/10.1210/clinem/dgad261
https://doi.org/10.1210/clinem/dgad261
Management of traditional risk factors for the development and progression of chronic kidney disease
Publikováno v:
Clinical Kidney Journal.
Chronic kidney disease (CKD) and its downstream complications (i.e., cardiovascular) are a major source of morbidity worldwide. Additionally, deaths due to CKD or CKD-attributable cardiovascular disease account for a sizeable proportion of global mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33babe7983f69cd45a8e847e8ff5ac4f
https://doi.org/10.1093/ckj/sfad101
https://doi.org/10.1093/ckj/sfad101
Autor:
Connie M. Rhee, Yoko Narasaki, Rene Amel Peralta, Yalitzi Guerrero, Amy S. You, Alejandra Novoa, Alpesh Amin, David Price, Andrea Daza, Danh V. Nguyen, Elisa Park, Kamyar Kalantar-Zadeh
Publikováno v:
Seminars in Dialysis. 34:388-393
Diabetes is the leading cause of end-stage renal disease (ESRD) and contributes to heightened morbidity and mortality in dialysis patients. Given that ESRD patients are susceptible to hypoglycemia and hyperglycemia via multiple pathways, adequate gly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1b03ed304e632653a6ab47b41906172
https://doi.org/10.1111/sdi.13009
https://doi.org/10.1111/sdi.13009
Autor:
Amy S, You, Sara S, Kalantar, Keith C, Norris, Rene Amel, Peralta, Yoko, Narasaki, Ronald, Fischman, Michael, Fischman, Avedik, Semerjian, Tracy, Nakata, Zahra, Azadbadi, Danh V, Nguyen, Kamyar, Kalantar-Zadeh, Connie M, Rhee
Publikováno v:
Journal of nephrology, vol 35, iss 5
Background Dialysis patients experience a high symptom burden, which may adversely impact their quality of life. Whereas other specialties emphasize routine symptom assessment, symptom burden is not well-characterized in dialysis patients. We sought
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75e1c9ffe5e3454b77380cdb677effae
https://escholarship.org/uc/item/0520k4gv
https://escholarship.org/uc/item/0520k4gv
Autor:
Yuhei Otobe, Danh Nguyen, Yalitzi Guerrero, Yoko Narasaki, Amy You, Kamyar Kalantar-Zadeh, Connie Rhee
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Low physical activity is common in hemodialysis (HD) patients and is associated with adverse outcomes in this population (poor health-related quality of life, cardiovascular [CV] disease, death). Prior studies show that hypothyroi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c475dfff5da0d640220ea67399a9c626
https://doi.org/10.1093/ndt/gfac083.062
https://doi.org/10.1093/ndt/gfac083.062